Nifty
Sensex
:
:
23250.10
76295.36
-82.25 (-0.35%)
-322.08 (-0.42%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 544067 | NSE: INNOVACAP

950.55
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  978.00
  •  983.90
  •  924.00
  •  1007.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  177604
  •  1683.52
  •  1260.00
  •  421.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,137.65
  • 40.33
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,378.18
  • N/A
  • 5.53

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.90%
  • 0.96%
  • 26.96%
  • FII
  • DII
  • Others
  • 0.74%
  • 12.70%
  • 7.74%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 10.54

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 9.97

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 13.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
11.91
P/E Ratio
85.58
Revenue
865
1391
1917
2267
EBITDA
154
211
293
358
Net Income
94
143
199
249
ROA
7.4
P/B Ratio
7.02
5.97
4.98
4.13
ROE
14.69
13.31
14.96
19.9
FCFF
245.65
-1791.2
1084.4
902.5
FCFF Yield
3.99
-29.11
17.63
14.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
316.46
302.49
4.62%
318.20
282.94
12.46%
294.27
233.24
26.17%
262.63
240.94
9.00%
Expenses
269.90
257.89
4.66%
268.47
242.47
10.72%
252.09
201.94
24.83%
224.56
214.15
4.86%
EBITDA
46.56
44.60
4.39%
49.73
40.48
22.85%
42.18
31.30
34.76%
38.08
26.80
42.09%
EBIDTM
14.71%
14.74%
15.63%
14.31%
14.33%
13.42%
14.50%
11.12%
Other Income
4.33
2.34
85.04%
2.22
3.34
-33.53%
2.12
1.13
87.61%
5.69
2.62
117.18%
Interest
0.17
6.80
-97.50%
0.15
8.81
-98.30%
0.14
5.03
-97.22%
0.81
5.23
-84.51%
Depreciation
5.13
4.93
4.06%
4.99
4.83
3.31%
4.85
2.79
73.84%
3.41
2.94
15.99%
PBT
45.59
35.20
29.52%
46.81
30.18
55.10%
39.31
24.60
59.80%
39.55
21.25
86.12%
Tax
11.38
10.07
13.01%
11.80
7.28
62.09%
9.83
7.01
40.23%
10.82
3.99
171.18%
PAT
34.20
25.13
36.09%
35.00
22.91
52.77%
29.48
17.59
67.60%
28.72
17.25
66.49%
PATM
10.81%
8.31%
11.00%
8.10%
10.02%
7.54%
10.94%
7.16%
EPS
5.98
4.39
36.22%
6.12
4.77
28.30%
5.15
3.67
40.33%
5.02
3.59
39.83%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
1,191.56
1,081.31
926.38
800.53
410.66
Net Sales Growth
12.45%
16.72%
15.72%
94.94%
 
Cost Of Goods Sold
784.33
579.35
552.63
529.46
273.02
Gross Profit
407.23
501.96
373.76
271.07
137.65
GP Margin
34.18%
46.42%
40.35%
33.86%
33.52%
Total Expenditure
1,015.02
926.85
812.73
704.51
356.18
Power & Fuel Cost
-
20.39
9.51
7.91
5.48
% Of Sales
-
1.89%
1.03%
0.99%
1.33%
Employee Cost
-
90.66
54.80
40.46
22.33
% Of Sales
-
8.38%
5.92%
5.05%
5.44%
Manufacturing Exp.
-
177.68
152.24
100.72
43.28
% Of Sales
-
16.43%
16.43%
12.58%
10.54%
General & Admin Exp.
-
30.03
23.39
15.22
8.59
% Of Sales
-
2.78%
2.52%
1.90%
2.09%
Selling & Distn. Exp.
-
15.67
14.24
6.93
2.18
% Of Sales
-
1.45%
1.54%
0.87%
0.53%
Miscellaneous Exp.
-
13.07
5.93
3.81
1.30
% Of Sales
-
1.21%
0.64%
0.48%
0.32%
EBITDA
176.55
154.46
113.65
96.02
54.48
EBITDA Margin
14.82%
14.28%
12.27%
11.99%
13.27%
Other Income
14.36
12.49
9.20
2.88
1.37
Interest
1.27
21.46
19.97
5.68
3.93
Depreciation
18.38
15.96
11.08
7.50
5.59
PBT
171.26
129.53
91.80
85.72
46.34
Tax
43.83
35.18
23.84
21.77
11.84
Tax Rate
25.59%
27.16%
25.97%
25.40%
25.55%
PAT
127.40
94.34
67.95
63.95
34.50
PAT before Minority Interest
127.40
94.34
67.95
63.95
34.50
Minority Interest
0.00
0.00
0.00
0.00
0.00
PAT Margin
10.69%
8.72%
7.34%
7.99%
8.40%
PAT Growth
53.72%
38.84%
6.25%
85.36%
 
EPS
22.27
16.49
11.88
11.18
6.03

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
830.89
276.51
208.61
144.82
Share Capital
57.23
48.00
12.00
12.00
Total Reserves
773.67
228.51
196.61
132.82
Non-Current Liabilities
204.55
194.16
88.09
44.49
Secured Loans
208.20
62.34
40.36
6.00
Unsecured Loans
0.00
71.83
26.99
0.00
Long Term Provisions
9.14
46.82
18.23
36.09
Current Liabilities
293.98
277.55
315.47
215.15
Trade Payables
179.66
158.48
144.80
112.23
Other Current Liabilities
57.98
20.55
28.30
68.96
Short Term Borrowings
23.84
97.94
120.09
33.43
Short Term Provisions
32.50
0.58
22.27
0.53
Total Liabilities
1,329.42
748.22
612.17
404.46
Net Block
357.88
182.88
183.03
79.14
Gross Block
406.39
215.53
205.97
106.64
Accumulated Depreciation
48.51
32.65
22.93
27.50
Non Current Assets
721.17
305.75
212.17
134.01
Capital Work in Progress
340.79
21.54
0.03
7.26
Non Current Investment
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
22.00
101.07
28.82
47.60
Other Non Current Assets
0.50
0.26
0.28
0.00
Current Assets
608.25
442.47
400.00
270.46
Current Investments
0.00
0.00
0.00
0.00
Inventories
144.02
117.32
128.39
91.44
Sundry Debtors
288.49
265.22
212.69
138.55
Cash & Bank
86.75
18.88
2.44
11.89
Other Current Assets
88.99
13.45
6.41
2.52
Short Term Loans & Adv.
80.08
27.61
50.08
26.05
Net Current Assets
314.27
164.92
84.53
55.31
Total Assets
1,329.42
748.22
612.17
404.47

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 21
Cash From Operating Activity
146.34
67.12
41.57
PBT
129.53
91.80
46.34
Adjustment
37.16
25.92
9.59
Changes in Working Capital
7.31
-31.06
-1.14
Cash after chg. in Working capital
174.00
86.65
54.80
Interest Paid
0.00
0.00
0.00
Tax Paid
-27.66
-19.53
-13.23
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-498.97
-90.84
-19.67
Net Fixed Assets
-329.82
-113.42
Net Investments
0.00
-60.00
Others
-169.15
82.58
Cash from Financing Activity
360.83
27.09
-19.34
Net Cash Inflow / Outflow
8.20
3.37
2.56
Opening Cash & Equivalents
3.52
0.15
2.23
Closing Cash & Equivalent
11.73
3.52
4.80

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
145.20
57.61
43.46
30.17
ROA
9.08%
9.99%
12.58%
10.48%
ROE
17.04%
28.02%
36.19%
27.04%
ROCE
19.06%
24.34%
30.64%
28.42%
Fixed Asset Turnover
3.48
4.46
5.17
4.09
Receivable days
93.25
92.78
79.30
100.13
Inventory Days
44.01
47.70
49.63
69.74
Payable days
106.52
100.16
88.60
122.96
Cash Conversion Cycle
30.74
40.32
40.33
46.92
Total Debt/Equity
0.29
0.85
0.95
0.31
Interest Cover
7.04
5.60
16.09
12.80

Annual Reports:

News Update:


  • Innova Captab - Quarterly Results
    5th Feb 2025, 17:11 PM

    Read More
  • Innova Captab commences commercial production at Jammu facility
    15th Jan 2025, 09:58 AM

    With this expansion, the company, at a consolidated level, has total five manufacturing facilities with nine independent manufacturing blocks

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.